• Quick Order
  • Careers
  • Support
Breast cancer cells Credit Annie Cavanagh.jpg

AACR Annual Meeting 2024

San Diego Convention Center, San Diego, California

April 05, 2024 - April 10, 2024

The AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. Attendees are invited to stretch their boundaries, form collaborations, attend sessions outside their own areas of expertise, and learn how to apply exciting new concepts, tools, and techniques to their own research. Join us at booth #1413 to explore our products and resources for oncology and immuno-oncology. Feel free to view some of our content around cancer diagnostics and drug development below.

Want to speak to one of ATCC’s representatives about a product or service? Contact us so we can discuss your needs.

Contact us

Cancer immunotherapy white oral squamous red cytotoxic T-cells

Human Cancer Models Initiative

ATCC is collaborating with the Human Cancer Models Initiative (HCMI) to offer scientists a wide variety of next-generation 2-D and 3-D patient-derived in vitro cancer models, including organoids.

ATCC is committed to making available a growing collection of models generated by the HCMI, which will include both common as well as rare and understudied examples of cancer from numerous tissues. These HCMI models are valuable tools to study cancer, identify and target novel therapies, and facilitate translational cancer research.

Find next-generation models

Download a PDF of our featured literature

Immune checkpoint inhibitors: Interaction between PD-1 (blue) on a T-cell and PD-L1 (red) on a cancer cell blocked by therapeutic antibodies Brochure

Immuno-oncology Capabilities

ATCC provides a large collection of fully characterized and authenticated cell lines, human primary cells, and advanced cell models such as checkpoint luciferase reporter cells and CAR-T target luciferase reporter cells that support immuno-oncology therapeutic development.

Blue and black cells. Brochure

Cell Lines by Gene Mutation

This guide organizes our ATCC tumor cell lines according to gene of interest and provides information for each line about the specific mutation.

Gloved hand holding metal pointer over DNA sequence on digital display screen. Brochure

Genetic Alteration Cell Panel

A comprehensive guide providing details and data on our AKT, BRAF, EGFR, ERK, FGFR, MET, MYC, PI3K, PTEN, and RAS genetic alteration cell panels.

A bright-blue, fluorescent, DAPI stain sphere with a black background. Brochure

Isogenic Cell Lines

With genome editing tools such as CRISPR/Cas9, ATCC has created isogenic cell lines with mutants of key oncogenes, which are ideal for identifying novel, personalized treatment regimens. Explore our resources.

Blue and red lung cancer cells. Brochure

ATCC Tumor Cell Panels by Gene Mutations and Tissue Origin

The value of tumor cell lines, as research models and drug discovery tools, is greatly enhanced when there is an understanding of the underlying genetic abnormalities that drive their phenotype. ATCC has taken the first step for your research by annotating our tumor cell lines with gene mutation data from the Sanger Institute COSMIC database, and additional in-house testing.

Pink and red HGF atubulin 2 hepatocyte line. Brochure

Tumor/Normal Matched Cell Line Pairs

Tumor-derived cell lines matched to either normal or metastatic cell lines obtained from the same patient provide a valuable resource for cancer studies.


Contact us today

Your ATCC sales representative stands ready to discuss your research needs and provide you with personalized care. Please complete our form to let us know how we can help, and we will start working on your needs right away.

We will not share your information outside of our distributors network and solely use it to send relevant communications.
Your form was successfully submitted